Future Role of CPX-351 and CPX-351-Based Combinations
In this Meet the Professor session in acute myeloid leukemia, Jeffrey Lancet, MD, chair of the Department of Malignant Hematology at the Moffitt
Educational Resources
Acute Myeloid Leukemia
Meetings / Conferences
SOHO 2025
Leukemia News
News
Lymphoma
Mantle Cell Lymphoma
News
FDA grants breakthrough therapy designation to sonrotoclax in relapsed or refractory MCL
The United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for sonrotoclax, a next-generation investigational BCL2 inhibitor, for adult patients with
SOHO 2025
Leukemia News
Drs. Kantarjian and Mauro discuss ELVN-001 in CML
In this video interview, Hagop Kantarjian, MD, speaks with Michael Mauro, MD, leader of the CML program at Memorial Sloan Kettering Cancer Center,
Leukemia
Acute Myeloid Leukemia
SOHO Insider Podcast
Dr. Eytan Stein joins Dr. Saad Usmani on SOHO Insider podcast
Saad Usmani, MD, chief of the myeloma service and Eytan Stein, MD, chief of the leukemia service, both from Memorial Sloan Kettering Cancer
SOHO 2025
Lymphoma News
News
BTK ‘degrader’ bexdeg shines in Waldenström macroglobulinemia
Attendees of SOHO 2025 will get a closer look at positive early safety and efficacy data for the novel Bruton’s tyrosine kinase (BTK)-targeted
Ambassador Program
SOHO 2025
News
The global impact of SOHO
With more than 10,500 global members, SOHO is poised to educate hematologic oncologists from every corridor of the Earth.
Leukemia
Chronic Lymphocytic Leukemia
SOHO 2025
Leukemia News
News
22-year study highlights disparities in CLL mortality rates
Death from chronic lymphocytic leukemia (CLL) in the U.S. has been declining, but disparities in outcomes persist, according to a population study of
SOHO 2025
Lymphoma News
Leukemia News
News
Young Investigator Program
Next-gen hem/oncs engage in new CLL/SLL educational pilot program at SOHO 2025
The Society of Hematologic Oncology (SOHO) created the Young Investigator Program (YIP) to support the training and development of young investigators and to promote quality
Leukemia
Acute Myeloid Leukemia
News
FDA grants Orphan Drug Designation for AK117 (ligufalimab)
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to AK117 (ligufalimab) for the treatment of acute myeloid leukemia (AML).
Meetings / Conferences
SOHO 2025
Lymphoma News
B-, T-cell lymphoma diagnostic test launched at SOHO 2025
The commercial launch of a new blood cancer test for patients with B- and T-cell lymphomas took place during the Thirteenth Annual Meeting